S y n t h e s i s i n C u l t u r e d F i b r o b l a s t s a n d Chond r o c y t e s b y a C a r t i l a g e -D e r i v e d Growth F a c t o r . C h i l d r e n ' s H o s p i t a l M e d i c a l C e n t e r a n d H a r v a r d M e d i c a l S c h o o l , B o s t o n , Mass. 02115. A g r o w t h f a c t o r d e r i v e d f r o m b o v i n e c a r t i l a g e i s d e s c r i b e d w h i c h s t i m u l a t e s DNA s y n t h e s i s a n d c e l l d i d v i s i o n i n c u l t u r e d f i b r o b l a s t s a n d c h o n d r o c y t e s . T h i s g r o w t h f a c t o r i s o b t a i n e d b y e x t r a c t i o n o f b o v i n e
s c a p u l a r c a r t i l a g e f r o m 1-14 d a y o l d c a l v e s w i t h 1 M g u a n i d i n e hydrochloride. F u r t h e r p u r i f i c a t i o n i s a c h i e v e d b y i o n e x c h a n g e c h r o m a t o g r a p h y u s i n g a c a t io n i c i o n e x c h a n g e r e s i n .
The a c t i v e f r a c t i o n i s e l u t e d w i t h 0.02M ammonium a c e t a t e , pH 8.5. T h i s f r a c t i o n s t i m u l a t e s DNA s y n t h e s i s i n mouse Balb/c-3T3 c e l l s a n d NIH/3T3 c e l l s .
I t a l s o s t i m u l a t e s DNA s y n t h e s i s i n c o n f l u e n t , r e s t i n g c h o n d r o c y t e s c u l t u r e d f r o m s c a p u l a r c a r t i l a g e o f a d u l t N e w Z e a l a n d w h i t e r a b b l t s . The g r o w t h f a c t o r i s i n a c t i v a t e d b y t r y p s i n . On g e l f i lt r a t i o n i n 4M g u a n i The secondary hyperparathyroidism (HPT) present i n normocalcemic v i t D.D.R. i s not clearly understood. Recent studies indicat i n g t h a t a feed-back loop m y be present between PTH and 1,25 dihydromycholecalciferol, we have examined the acute e f f e c t of a v i t D loed on-serum iPTH levels i n 5 infants (age 5 t o 11 monthsj with normocalcemic v i t D. D. R. They a l l presented a c l i n i c a l histor y compatible with v i t D deficiency and marked t y p i c a l bone lesions of rickets. Serum 08, ranged from 8 , 9 t o 9,6 mg/100ml, serum P from 3,8 t o 5,5 mg/lOOml and serum alkaline phosphatases(A.~ase) from 84 t o 225 iu(N00). Elevated serum iPTH levels were present: 280 t o 670 plEq/ml(~<lOO), A unique o r a l v i t D load (600 000 u) was given. In a l l infants a marked decrease in2serum iPTH was o b served 24 and 48 h l a t e r (serum iPTH a t 48 h : 115 t o 360 ~lEq/ml -A~PTFI : 140 t o 450 p~q / m l ) with no consistent changes i n serum Ca, P and A.Pase. Normal levels of serum iPTH were found on a cont r o l 10 t o 18 days l a t e r , though serum A.Pase remained elevated and healing of bone lesions was incomplete. These r e s u l t s suggest t h a t the HPTof normocalcemic v i t D.D.R.
i s , a t l e a s t i n p a r t , dir e c t l y secondary t o the lack of active metabolites of v i t D, prcbably 1.25 dihydroxy v i t D ; they a r e a l s o consistent with the concept of a feed-back loop between PTH and vitamin D metabolites.
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R o t t e r d a m , The N e t h e r l a n d s K i n d e r k l i n i k , Med.Hochschule Hannover Serum somatomedin (SM) a n d cartilage m e t a b o l i s m i n mal-M e d . K l i n i k , F U B e r l i n , Klinikum S t e o l i t z nourished a n d r e f e d r a t s .
SM a n d l n h l b l t o r s w e r e estimated b y t h e p o r c l n e b l oa s s a y i n a c u t e l y f a s t e d , marasmlc (M) a n d marasmlc-kwash i o r k o r (MK) r a t s . I n v l t r o e n d o g e n o u s a c t l v l t y a n d lesp o n s l v e n e s s t o SM was m e a s u r e d I n t h e l r c o s t a l c a r t l l a g e u s l n g ~3 5 -s u l f a t e a n d ~3 -t h y m i d m e . A c u t e f a s t l n g f o r 3-4 d a y s r e s u l t e d i n c q m p l e t e l o s s o f SM a c t l v l t y , p a r t l y c a u s e d b y a h e a t -l a b i l e , n o n -d~a l y s a b l e l n h i b l t o r . C a r t l l a g e e n d o g e n o u s a c t l v l t y a n d responsiveness were d e p r e s s On r e f e e d i n g M r a t s , SM a n d c a r t l l a g e r e s p o n s i v e n e s s I nc r e a s e d b y 24 h r s a n d c a r t i l a g e e n d o g e n o u s a c t l v i t y b y 48 h r s . However c a t c h -u p g r o w t h I n l e n g t h s e e n a f t e r 1 a n d 2 weeks was b e s t r e f l e c t e d by ~3 -t h y m l d l n e u p t a k e . C l e a r l y differences I n SM a c t l v l t y a n d t a r g e t o r g a n met a b o l l s m f o l l o w different n u t r l t l o n a l ~n s u l t s . F u r t h e r s t u d i e s o f t h e s e m o d e l s may c l a r l f y t h e r e l a t l v e r o l e s o f SM a n d l n h l b l t o r s I n m a l n u t r l t l o n . SCHWAI,BE,S. L. , RAYNER P.H.W. , RUDD B.T.
SMITH M. , I n s t i t u t e o f C h i l d H e a l t h , U n i v e r s i t y o f Birmingham, BIRMINGHAM, U.K. Somatomedin A c t i v i t y i n Growth D i s o r d e r s .

Somatomedln a c t i v i t y (SMA) h a s b e e n measured u s i n g a n embryonic c h i c k c a r t i l a g e a s s a y i n n o r m a l a n d s h o r t n o r m a l c h i l d r e n , c h i l d r e n w i t h r e t a r d e d g r o w t h due t o p i t u i t a r y GEE d e f i c i e n c y a n d c h i l d r e n w i t h a c c e l e r a t e d growth due t o s e x u a l p r e c o c i t y .
Samples were t a k e n f a s t i n g b e t w e e n 09.00 a n d 1 0 . 3 0 h o u r s . P o o l e d a d u l t serum was u s e d a s r e f e r e n c e s t a n d a r d . The f o l l o w i n g r e s u l t s were o b t a i n e d : n o r m a l a n d s h o r t n o r m a l ( n = 2 3 ) 1 . 0 6~ 0 . 2 7 , GH d e f i c i e n c y ( n = 2 0 ) 0 . 8 1 t 0.19 ( p C 0 . 0 0 1 ) , s e x u a l p r e c o c i t y ( n = 1 1 ) L . 2 7 t 0.22 ( p < 0 . 0 2 ) .
I n a l l g r o u p s a h i g h l y s i g n i f i c a n t c o r r e l a t i o r~ w i t h bone a g e ( r = 0.78) h a s b e e n d o m o n s t r a t e d .
The a c u t e s h o r t t e r m e f f e c t o f HGH a d m i n i s t r a t i o n on SMA i n 1 2 c h i l d r e n h a s a l s o b e e n s t u d i e d t o o b t a i n a predictive i n d e x o f g r o w t h r e s p o n s e .
A s i g n i f i c a n t r e s p o n s e was n o t s e e n i n a n y c h i l d r e n w i t h i n 48 h o u r s f o l l o w i n g HGH 1 0 mgs I . M .
A r e s p o n s e d i d o c c u r a t 3 a n d 6 h o u r s f o l l o w i n g a s e c o n d i n j e c t i o n i n 6 c h i l d r e n .
The e f f e c t of h y p e r p a r a t h y r o i d i s m on t u b u l a r r e a b s o r pt i o n o f amino a c i d s I n v i t a m i n D r e s i s t e n t r i c k e t s ( V D R R ) The t u b u l a r r e a b s o r p t i o n o f amino a c i d s was i n v e s t i o a t e d i n 15 c h i l d r e n w i t h V D R R b e f o r e t r e a t m e n t , f o l l o w i n o an a c u t e i n j e c t i o n o f PTH, and a f t e r development of s e c o nd a r y h y p e r p a r a t h y r o i d i s m i n d u c e d by c o n t i n o u s o r a l phosp h a t e s u b s t i t u t i o n
. R e f o r e t r e a t m e n t 5 of 6 c h i l d r e n had normal serum v a l u e s of iPTH ( 2 2 , 5 U / m l ) . None of 1 5 p a t i e n t s showed a o e n e r a l i z e d d e f e c t i n amino a c i d r e a bs o r p t i o n , however t u b u l a r r e a b s o r p t i o n o f o l y c i n e was s i o n i f i c a n t l y reduced i n 10 p a t i e n t s ( $T-cly = 9 0 , 7 % v s . 9 6 , 5 % in n o r m a l s ) . A f t e r a n a c u t e i . A.A., born a t term, weight 3350 g, was the first child of healthy and related Turkish parents. He was admitted for investigation of "black urine". Homogentisinic acid was identified and alcaptonuria thus proven. In addition, he showed severe bone changes compatible with hyperparathyroidism. This diagnosis was corroborated by : progressive hypercalcemia (up to 15.5 mg%), low serum Pi (2.6 to 4.5 mg%), concomittant increase of aIk.P1ase (85-168 IU) and of aminoaciduria, and high immunoreactive parathyroid hormone (iPTH, 900 ng/ml, normal <40 ng/ml). After low calcium diet, withdrawal of daily vit.D3 supplement (400 IU) and under hydrocortisone vit.D deficiency rickets developped : serum Ca fell to 7J mg%, Pi to 1.9 mg%, alk.Ptase rose to 240 IU, hyperaminoaciduria increased, iPTH was 283 ng/ml. Vit.D3 therapy, 1000 IU/day, a dose normally sufficient to restore normocalcemia and to heal vit.D deficiency rickets, led to a relapse of hypercalcernia (serum Ca 13.6 mg%) within 4 days. Four parathyroid glands with histologically diffuse hyperplasia were removed. Within 1 day, serum iPTH and Ca dropped and hyperaminoaciduria disappeared. Alcaptonuria persisted. Postoperative hypoparathyroidism was treated with 1,25(OH)2D3 (1 ,ug/day) and calcium supplement, and normocalcemia was achieved. The course of the disease will be reported and the biochemical findings be discussed.
